Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the mptp-lesioned nonhuman primate

Synapse

Volumn 64, Issue 2, 2010, Pages 177-180

  Silverdale, Monty A ^a   Kobylecki, Christopher ^a   Hallett, Penelope J ^b   Li, Qin ^c   Dunah, Anthone W ^b   Ravenscroft, Paula ^d   Bezard, Erwan ^d   Brotchie, Jonathan M ^e  

^a HOPE HOSPITAL   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cellular fractionation; Macaque; MPTP; Parkinson's disease; Trafficking; Western blotting

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMPA RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; LEVODOPA; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN HOMOGENATE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; DYSKINESIA; FEMALE; IMMUNOBLOTTING; MACACA; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; WESTERN BLOTTING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIPARKINSON AGENTS; CELL MEMBRANE; DYSKINESIA, DRUG-INDUCED; FEMALE; LEVODOPA; MACACA MULATTA; NEOSTRIATUM; NEURONS; PARKINSONIAN DISORDERS; RECEPTORS, AMPA; SYNAPSES; SYNAPTIC VESICLES;

EID: 72449160194     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20739     Document Type: Article

References (33)

1. Ba M, Kong M, Yang H, Ma G, Lu G, Chen S, Liu Z. 2006. Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats. Neurochem Res 31:1337-1347. (Pubitemid 44800585)
2. Berthet A, Porras G, Doudnikoff E, Stark H, Cador M, Bezard E, Bloch B. 2009. Pharmacological analysis demonstrates dramatic alteration of D1 Dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia. J Neurosci 29:4829-4835.
3. Bezard E, Brotchie JM, Gross CE. 2001a. Pathophysiology of levo-dopa-induced dyskinesia: potential for new therapies. Nat Rev 2:577-588. (Pubitemid 33679831)
4. Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE. 2001b. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Neurosci 21:6853-6861.
5. Bezard E, Ferry S, Mach U, Stark H, Leriche L, Boraud T, Gross C, Sokoloff P. 2003. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat Med 9:762-767. (Pubitemid 36749227)
6. Bibbiani F, Oh JD, Kielaite A, Collins MA, Smith C, Chase TN. 2005. Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Exp Neurol 196:422-429. (Pubitemid 41607831)
7. Blanchet PJ, Konitsiotis S, Chase TN. 1998. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys. Mov Disord 13:798-802. (Pubitemid 28429978)
8. Blanchet PJ, Konitsiotis S, Whittemore ER, Zhou ZL, Woodward RM, Chase TN. 1999. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl- tetrahydropyridine monkeys. J Pharmacol Exp Therapeutics 290:1034-1040. (Pubitemid 29400241)
9. Calon F, Morissette M, Ghribi O, Goulet M, Grondin R, Blanchet PJ, Bedard PJ, Di Paolo T. 2002. Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Prog Neuro-psychopharmacol Biol Psychiatry 26:127-138.
10. Calon F, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T. 2003. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. Neurobiol Dis 14:404-416. (Pubitemid 37543519)
11. Chase TN, Oh JD. 2000. Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci 23(10 Suppl):S86-S91.
12. Dekundy A, Pietraszek M, Schaefer D, Cenci MA, Danysz W. 2006. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. Brain Res Bull 69:318-326.
13. Deng YP, Xie JP, Wang HB, Lei WL, Chen Q, Reiner A. 2007. Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats. J Chem Neuroanatomy 33:167-192. (Pubitemid 46755539)
14. Dunah AW, Standaert DG. 2001. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci 21:5546-5558.
15. Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, Standaert DG. 2000. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 57:342-352. (Pubitemid 30084511)
16. Fahn S. 2000. The spectrum of levodopa-induced dyskinesias. Ann Neurol 47(Suppl 1):S2-S9; discussion S9-S11.
17. Fiorentini C, Rizzetti MC, Busi C, Bontempi S, Collo G, Spano P, Missale C. 2006. Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat. Mol Pharmacol 69:805-812. (Pubitemid 43363855)
18. Gardoni F, Picconi B, Ghiglieri V, Polli F, Bagetta V, Bernardi G, Cattabeni F, Di Luca M, Calabresi P. 2006. A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci 26:2914-2922.
19. Guigoni C, Doudnikoff E, Li Q, Bloch B, Bezard E. 2007. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Neurobiol Dis 26:452-463. (Pubitemid 46561343)
20. Hadj Tahar A, Gregoire L, Darre A, Belanger N, Meltzer L, Bedard PJ. 2004. Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys. Neurobiol Dis 15:171-176. (Pubitemid 38296747)
21. Hallett PJ, Collins TL, Standaert DG, Dunah AW. 2008. Biochemical fractionation of brain tissue for studies of receptor distribution and trafficking. Curr Protoc Neurosci 42:1.16.1-1.16.16.
22. Hallett PJ, Dunah AW, Ravenscroft P, Zhou S, Bezard E, Crossman AR, Brotchie JM, Standaert DG. 2005. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology 48:503-516. (Pubitemid 40332408)
23. Jenner P. 2008. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev 9:665-677.
24. Konitsiotis S, Blanchet PJ, Verhagen L, Lamers E, Chase TN. 2000. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys. Neurology 54:1589-1595. (Pubitemid 30226801)
25. Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA. 2004. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiol Dis 17:219-236. (Pubitemid 39345778)
26. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL. 2000. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405:955-959. (Pubitemid 30435052)
27. Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA. 2007. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease. J Neurochem 101:483-497. (Pubitemid 46525288)
28. Oh JD, Russell DS, Vaughan CL, Chase TN. 1998. Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: Effect of dopaminergic denervation and L-DOPA administration. Brain Res 813:150-159.
29. Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. 2003. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 6:501-506. (Pubitemid 36514698)
30. Price CJ, Kim P, Raymond LA. 1999. D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors. J Neurochem 73:2441-2446.
31. Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, Girault JA, Herve D, Greengard P, Fisone G. 2007. Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J Neurosci 27:6995-7005. (Pubitemid 47015907)
32. Silverdale MA, Crossman AR, Brotchie JM. 2002. Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia. Exp Neurol 174: 21-28.
33. Wang WW, Cao R, Rao ZR, Chen LW. 2004. Differential expression of NMDA and AMPA receptor subunits in DARPP-32-containing neurons of the cerebral cortex, hippocampus and neostriatum of rats. Brain Res 998:174-183. (Pubitemid 38125058)